{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:03:34Z","timestamp":1791497014844,"version":"4.3.4"},"reference-count":51,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18TPA34170206"],"award-info":[{"award-number":["18TPA34170206"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Group B coxsackieviruses (CVB) containing six serotypes, B1\u2013B6, affect various organs, and multiple serotypes can induce similar diseases such as myocarditis and pancreatitis. Yet, no vaccines are currently available to prevent these infections. Translationally, the derivation of vaccines that offer protection against multiple serotypes is highly desired. In that direction, we recently reported the generation of an attenuated strain of CVB3, termed Mt10, which completely protects against both myocarditis and pancreatitis induced by the homologous wild-type CVB3 strain. Here, we report that the Mt10 vaccine can induce cross-protection against multiple CVB serotypes as demonstrated with CVB4. We note that the Mt10 vaccine could induce cross-reactive neutralizing antibodies (nABs) against both CVB1 and CVB4. In challenge studies with CVB4, the efficacy of the Mt10 vaccine was found to be 92%, as determined by histological evaluation of the heart and pancreas. Antibody responses induced in Mt10\/CVB4 challenged animals indicated the persistence of cross-reactive nABs against CVB1, CVB3, and CVB4. Evaluation of antigen-specific immune responses revealed viral protein 1 (VP1)-reactive antibodies, predominantly IgG2a, IgG2b, IgG3, and IgG1. Similarly, by using major histocompatibility complex class II tetramers, we noted induction of VP1-specific CD4 T cells capable of producing multiple T cell cytokines, with interferon-\u03b3 being predominant. Finally, none of the vaccine recipients challenged with CVB4 revealed the presence of viral nucleic acid in the heart or pancreas. Taken together, our data suggest that the Mt10 vaccine can prevent infections caused by multiple CVB serotypes, paving the way for the development of monovalent CVB vaccines to prevent heart and pancreatic diseases of enteroviral origin.<\/jats:p>","DOI":"10.3390\/microorganisms9112323","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T09:19:21Z","timestamp":1636535961000},"page":"2323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6762-2654","authenticated-orcid":false,"given":"Ninaad","family":"Lasrado","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Arumugam","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima T.","family":"Rasquinha","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0878-4930","authenticated-orcid":false,"given":"Meghna","family":"Sur","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-2296","authenticated-orcid":false,"given":"David","family":"Steffen","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-9254","authenticated-orcid":false,"given":"Jay","family":"Reddy","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-540-75546-3_10","article-title":"Pediatric group B coxsackievirus infections","volume":"323","author":"Romero","year":"2008","journal-title":"Group B Coxsackieviruses"},{"key":"ref_2","unstructured":"Tariq, N., and Kyriakopoulos, C. (2021). Group B Coxsackie Virus, StatPearls."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1172\/JCI104776","article-title":"Acute respiratory disease in normal volunteers associated with Coxsackie A-21 viral infection. III. Response to nasopharyngeal and enteric inoculation","volume":"42","author":"Spickard","year":"1963","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/rmv.2131","article-title":"An overview of the immune mechanisms of viral myocarditis","volume":"30","author":"Lasrado","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/vim.2004.17.358","article-title":"Coxsackievirus-induced pancreatitis","volume":"17","author":"Huber","year":"2004","journal-title":"Viral Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/BOR.0b013e328353372d","article-title":"Update on coxsackievirus B3 myocarditis","volume":"24","author":"Fairweather","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions","volume":"18","author":"Tschope","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fcell.2020.00192","article-title":"Triggers of Inflammatory Heart Disease","volume":"8","author":"Lasrado","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00125-014-3436-0","article-title":"A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models","volume":"58","author":"Larsson","year":"2015","journal-title":"Diabetologia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diabetes.49.5.708","article-title":"Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets","volume":"49","author":"Serreze","year":"2000","journal-title":"Diabetes"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/db13-0619","article-title":"Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes","volume":"63","author":"Laitinen","year":"2014","journal-title":"Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1128\/JVI.74.21.10153-10164.2000","article-title":"Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells","volume":"74","author":"Chehadeh","year":"2000","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Alhazmi, A., Nekoua, M.P., Michaux, H., Sane, F., Halouani, A., Engelmann, I., Alidjinou, E.K., Martens, H., Jaidane, H., and Geenen, V. (2021). Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061177"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMoa1911023","article-title":"Zika Virus Disease and Pregnancy Outcomes in Colombia","volume":"383","author":"Ospina","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vernet, M.A., Reynard, S., Fizet, A., Schaeffer, J., Pannetier, D., Guedj, J., Rives, M., Georges, N., Garcia-Bonnet, N., and Sylla, A.I. (2017). Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. JCI Insight, 2.","DOI":"10.1172\/jci.insight.88864"},{"key":"ref_16","unstructured":"Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S.C., and Di Napoli, R. (2021). Features, Evaluation, and Treatment of Coronavirus (COVID-19), StatPearls."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1038\/s41598-021-90434-w","article-title":"Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis","volume":"11","author":"Lasrado","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymeth.2006.07.009","article-title":"Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity","volume":"41","author":"Fairweather","year":"2007","journal-title":"Methods"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nsb1001-874","article-title":"Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor","volume":"8","author":"He","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/srep06803","article-title":"Matrix-assisted laser desorption\/ionization time-of-flight (MALDI-TOF) mass spectrometry applied to virus identification","volume":"4","author":"Calderaro","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_21","unstructured":"Dougherty, R., and Harris, R. (1964). Techniques in Experimental Virology, Academic Press."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cellimm.2011.08.013","article-title":"Identification of novel mimicry epitopes for cardiac myosin heavy chain-alpha that induce autoimmune myocarditis in A\/J mice","volume":"271","author":"Massilamany","year":"2011","journal-title":"Cell Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2012.07.003","article-title":"Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-alpha-reactive CD4 T cells in A\/J mice","volume":"144","author":"Gangaplara","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lasrado, N., Gangaplara, A., Arumugam, R., Massilamany, C., Pokal, S., Zhou, Y., Xiang, S.H., Steffen, D., and Reddy, J. (2020). Identification of Immunogenic Epitopes That Permit the Detection of Antigen-Specific T Cell Responses in Multiple Serotypes of Group B Coxsackievirus Infections. Viruses, 12.","DOI":"10.3390\/v12030347"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2009.11.006","article-title":"An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice","volume":"219","author":"Massilamany","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.170.2.870","article-title":"Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers","volume":"170","author":"Reddy","year":"2003","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jim.2011.07.004","article-title":"Detection of cardiac myosin heavy chain-alpha-specific CD4 cells by using MHC class II\/IA(k) tetramers in A\/J mice","volume":"372","author":"Massilamany","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molimm.2020.06.017","article-title":"Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection","volume":"124","author":"Basavalingappa","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.mie.2019.06.001","article-title":"LEGENDplex: Bead-assisted multiplex cytokine profiling by flow cytometry","volume":"629","author":"Lehmann","year":"2019","journal-title":"Methods Enzymol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0065-2776(08)00604-4","article-title":"Pathogenesis of myocarditis and dilated cardiomyopathy","volume":"99","author":"Cihakova","year":"2008","journal-title":"Adv. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/db13-0620","article-title":"Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes","volume":"63","author":"Oikarinen","year":"2014","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00125-002-0852-3","article-title":"The role of viruses in human diabetes","volume":"45","author":"Hyoty","year":"2002","journal-title":"Diabetologia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.diabet.2008.05.008","article-title":"Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes","volume":"34","author":"Jaidane","year":"2008","journal-title":"Diabetes Metab."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Honkimaa, A., Kimura, B., Sioofy-Khojine, A.B., Lin, J., Laiho, J., Oikarinen, S., and Hyoty, H. (2020). Genetic Adaptation of Coxsackievirus B1 during Persistent Infection in Pancreatic Cells. Microorganisms, 8.","DOI":"10.3390\/microorganisms8111790"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Coudeville, L., Bailleux, F., Riche, B., Megas, F., Andre, P., and Ecochard, R. (2010). Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: Development and application of a bayesian random-effects model. BMC Med. Res. Methodol., 10.","DOI":"10.1186\/1471-2288-10-18"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104712","DOI":"10.1016\/j.meegid.2021.104712","article-title":"Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19","volume":"89","author":"Rencilin","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3389\/fimmu.2019.02564","article-title":"VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4291\/wjgp.v7.i1.108","article-title":"Mechanisms of interleukin-22\u2032s beneficial effects in acute pancreatitis","volume":"7","author":"Huan","year":"2016","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2353\/ajpath.2006.060350","article-title":"Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders","volume":"169","author":"Szalay","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Loebbermann, J., Schnoeller, C., Thornton, H., Durant, L., Sweeney, N.P., Schuijs, M., O\u2019Garra, A., Johansson, C., and Openshaw, P.J. (2012). IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032371"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1038\/srep05344","article-title":"Protective role of TNF-alpha, IL-10 and IL-2 in mice infected with the Oshima strain of Tick-borne encephalitis virus","volume":"4","author":"Tun","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2337\/diabetes.51.6.1745","article-title":"Characterization of the T-cell response to coxsackievirus B4: Evidence that effector memory cells predominate in patients with type 1 diabetes","volume":"51","author":"Ellis","year":"2002","journal-title":"Diabetes"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.vaccine.2012.01.061","article-title":"Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis","volume":"30","author":"Zhang","year":"2012","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.01.013","article-title":"Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice","volume":"104","author":"Koho","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.vaccine.2009.01.008","article-title":"Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis","volume":"27","author":"Park","year":"2009","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00365549409008644","article-title":"Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses","volume":"26","author":"See","year":"1994","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"104595","DOI":"10.1016\/j.antiviral.2019.104595","article-title":"Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine","volume":"171","author":"Hankaniemi","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00125-017-4492-z","article-title":"A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes","volume":"61","author":"Stone","year":"2018","journal-title":"Diabetologia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00284-013-0498-z","article-title":"Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection","volume":"68","author":"Souii","year":"2014","journal-title":"Curr. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","article-title":"A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates","volume":"6","author":"Stone","year":"2020","journal-title":"Sci. Adv."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/11\/2323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:28:03Z","timestamp":1760167683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/11\/2323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["microorganisms9112323"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms9112323","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]}}}